Published 2 years agoUT Southwestern biotech company lands another $80M about 18 months after last raise Summary by The Business JournalsReCode Therapeutics is gearing up for human clinical trials of its primary ciliary dyskinesia (PCD) and cystic fibrosis therapies next year.Share menu0 Articles0 ArticlesAllLeftCenterRightThe Business JournalsCenterHigh FactualityMedia Conglomerate: Advance PublicationsUT Southwestern biotech company lands another $80M about 18 months after last raiseReCode Therapeutics is gearing up for human clinical trials of its primary ciliary dyskinesia (PCD) and cystic fibrosis therapies next year.2 years ago·United StatesRead Full ArticleThe Business JournalsCenterHigh FactualityMedia Conglomerate: Advance Publications UT Southwestern biotech company lands another $80M about 18 months after last raiseReCode Therapeutics is gearing up for human clinical trials of its primary ciliary dyskinesia (PCD) and cystic fibrosis therapies next year.2 years ago·United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeStories disproportionately reported by the Left or the RightSee More BlindspotsGround News Article Assistant Not enough coverage to generate an Article Assistant.Coverage DetailsTotal News Sources0Leaning Left0Leaning Right0Center1Last Updated2 years agoBias Distribution100% CenterBias Distribution 100% of the sources are Center100% CenterC 100%FactualityTo view factuality data please Upgrade to PremiumOwnership To view ownership data please Upgrade to VantageSources are mostly out of (0)Similar News TopicsBusinessDallas, TexasUS EconomyShow AllStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsBusinessDallas, TexasUS EconomyShow All